Image

Heparinization vs Salinization of the Peripheral Venous Catheter

Heparinization vs Salinization of the Peripheral Venous Catheter

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Randomized, double-blind clinical trial to compare the efficacy of catheter sealing with saline, compared to low-dose heparin. 3,450 patients hospitalized at the Hospital Residencia Sant Camil, in Catalonia (Spain), will be randomized to each branch of study. The primary outcome will be the percentage of catheters removed due to obstruction in each branch of study. As secondary outcomes, the number of catheter-associated phlebitis, catheter-associated bacetrihemia, extravasation, and catheter loss will be measured. For the primary outcome, a superiority analysis will be carried out in terms of the percentage of obstructed catheters in each branch of the study.

Eligibility

Inclusion Criteria:

  • Patients older than 18 yo, admitted to the Hospital Residencia Sant Camil
  • Patients with at least one peripheral venous line for discontinuous treatment, which has not been channeled in a medical emergency situation.
  • Written informed consent

Exclusion Criteria:

  • Allergy to heparin
  • Patients treated with unfractionated sodium heparin.
  • Patients in dialysis
  • Patients with a venous catheter indicated for diagnosis tests.
  • Patients with a venous catheter indicated for blood transfusion
  • Severe heparin-induced thrombocytopenia in recent months
  • Active uncontrollable bleeding during admission
  • Brain aneurysm or dissecting aorta, except in association with corrective surgery.
  • Confirmed / suspected cerebrovascular hemorrhage
  • Severe uncontrolled hypertension
  • Severe alterations in platelet coagulation <30,000, TP> 1.7 APTT ratio> 1.7 ratio.
  • Patient included in another clinical trial with drugs or procedures that may affect the patency of venous catheters.

Study details
    Catheter Complications

NCT05209841

Consorci Sanitari de l'Alt Penedès i Garraf

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.